Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by May Aziz
Evaluation of High-Dose Melphalan Toxicity by Age in Patients Undergoing Autologous Stem Cell Transplant for Multiple Myeloma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Related publications
Amifostine Reduces High-Dose Melphalan Induced Gastro-Intestinal Toxicity in Autologous Hematopoietic Cell Transplant (HCT) for Plasma Cell Myeloma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Acute Cognitive Impairment in Patients With Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplant
Cancer
Cancer Research
Oncology
High-Dose Therapy and Autologous Stem Cell Transplant in Older Adults With Multiple Myeloma
Bone Marrow Transplantation
Transplantation
Hematology
High-Dose BCNU/Melphalan Conditioning Regimen Before Autologous Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma
Bone Marrow Transplantation
Transplantation
Hematology
MBL2 Polymorphism and Risk of Severe Infections in Multiple Myeloma Patients Receiving High-Dose Melphalan and Autologous Stem Cell Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
Elevated Pre-Transplant C-Reactive Protein Identifies a High-Risk Subgroup in Multiple Myeloma Patients Undergoing Delayed Autologous Stem Cell Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
Phase I–II Evaluation of Rapid Sequence Tandem High-Dose Melphalan With Peripheral Blood Stem Cell Support in Patients With Multiple Myeloma
Bone Marrow Transplantation
Transplantation
Hematology
Autologous Stem Cell Transplantation in Multiple Myeloma Patients <60 vs 60 Years of Age
Bone Marrow Transplantation
Transplantation
Hematology
Autologous Stem Cell Transplantation Followed by Consolidation Chemotherapy for Patients With Multiple Myeloma
Bone Marrow Transplantation
Transplantation
Hematology
